| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Rheumatoid arthritis | 3 | 1 | |
| Diabetes type 2 | 1 | 1 | |
| Pernicious anemia | 1 | 1 | |
| Psoriatic arthritis | 1 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 1 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Rheumatoid arthritis | 3 | 1 | |
| Diabetes type 2 | 1 | 1 | |
| Pernicious anemia | 1 | 1 | |
| Psoriatic arthritis | 1 | 0 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 1 |